Laboratoire de Chimie de Coordination UPR 8241


Accueil

Bernard MEUNIER
DR
0561333184
B152

Présentation


Curriculum Vitae

Publications


2019

Huang, D., Li, Y., Liu, Y., & Meunier, B. (2019). Synthesis and chelation selectivity evaluation of 8-aminoquinoline derivatives as copper chelator. Chin. J. Org. Chem., 39(2), 500–506.

2018

Gumpelmayer, M., Nguyen, M., Molnar, G., Bousseksou, A., Meunier, B., & Robert, A. (2018). Magnetite Fe3O4 has no intrinsic peroxidase activity, and is probably not involved in Alzheimer's oxidative stress. Angew. Chem., Int. Ed., 57, 14758 –14763.
Meunier, B. (2018). Alzheimer : quand allons-nous avoir des médicaments efficaces ? Actualité Chimique, 433, 7.
Paloque, L., Witkowski, B., Lelievre, J., Ouji, M., Ben Haddou, T., Ariey, F., Robert, A., Augereau, J. - M., Menard, D., Meunier, B., & Benoit-Vical, F. (2018). Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. J. Antimicrob. Chemother., 73(2), 395–403.
Zhang, W., Huang, D., Huang, M., Huang, J., Wang, D., Liu, X., Nguyen, M., Vendier, L., Mazères, S., Robert, A., Liu, Y., & Meunier, B. (2018). Preparation of tetradentate copper chelators as potential anti‐Alzheimer agents. ChemMedChem, 13(7), 684–704.
Zhang, W., Huang, M., Bijani, C., Liu, Y., Robert, A., & Meunier, B. (2018). Synthesis and characterization of copper-specific tetradendate ligands as potential treatment for Alzheimer's disease. C. R. Chimie, 21(5), 475–483.
Zhang, W., Liu, Y., Hureau, C., Robert, A., & Meunier, B. (2018). N4‐Tetradentate chelators efficiently regulate copper homeostasis and prevent ROS production induced by copper‐amyloid‐β1–16. Chem. – Eur. J., 24(31), 7825–7829.

2017

Nguyen, M., Huang, M., Liu, Y., Meunier, B., & Robert, A. (2017). Is iron associated with amyloid involved in the oxidative stress of Alzheimer's disease? C. R. Chimie, 20(11), 987–989.
Nguyen, M., Meunier, B., & Robert, A. (2017). Catechol-based ligands as potential metal chelators inhibiting redox activity in Alzheimer's disease. Eur. J. Inorg. Chem., 2017(25), 3198–3204.
Nguyen, M., Vendier, L., Stigliani, J. - L., Meunier, B., & Robert, A. (2017). Structures of the copper and zinc complexes of PBT2, a chelating agent evaluated as potential drug for neurodegenerative diseases. Eur. J. Inorg. Chem., 2017(3), 600–608.